Legal
Key facts
Pomerantz LLP announced that a class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc
Key facts
Regeneron Pharmaceuticals, Inc. is identified as the company involved, with ticker NASDAQ: REGN
Key facts
The notice says the case concerns whether Regeneron and certain officers and/or directors engaged in securities…
Atlas Watchline
Pomerantz LLP says investors in Regeneron Pharmaceuticals have until Sept. 14, 2026, to seek lead-plaintiff status…